KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Short-term Investments (2018 - 2025)

Adaptive Biotechnologies' Short-term Investments history spans 8 years, with the latest figure at $156.5 million for Q4 2025.

  • For Q4 2025, Short-term Investments fell 10.26% year-over-year to $156.5 million; the TTM value through Dec 2025 reached $156.5 million, down 10.26%, while the annual FY2025 figure was $156.5 million, 10.26% down from the prior year.
  • Short-term Investments for Q4 2025 was $156.5 million at Adaptive Biotechnologies, down from $157.7 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $540.6 million in Q1 2021 and bottomed at $142.8 million in Q1 2025.
  • The 5-year median for Short-term Investments is $265.0 million (2022), against an average of $269.8 million.
  • The largest YoY upside for Short-term Investments was 102.12% in 2021 against a maximum downside of 62.11% in 2021.
  • A 5-year view of Short-term Investments shows it stood at $214.0 million in 2021, then surged by 90.74% to $408.2 million in 2022, then tumbled by 31.07% to $281.3 million in 2023, then plummeted by 38.02% to $174.4 million in 2024, then dropped by 10.26% to $156.5 million in 2025.
  • Per Business Quant, the three most recent readings for ADPT's Short-term Investments are $156.5 million (Q4 2025), $157.7 million (Q3 2025), and $154.7 million (Q2 2025).